Market revenue in 2023 | USD 564.2 million |
Market revenue in 2030 | USD 1,145.0 million |
Growth rate | 10.6% (CAGR from 2023 to 2030) |
Largest segment | Scaffold based |
Fastest growing segment | Scaffold Free |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, PROMOCELL, Lonza Group Ltd, Corning Inc, Avantor Inc, Tecan Group AG, ReproCELL, CN Bio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d cell culture market will help companies and investors design strategic landscapes.
Scaffold based was the largest segment with a revenue share of 48.94% in 2023. Horizon Databook has segmented the U.S. 3d cell culture market based on scaffold based, scaffold free, bioreactors, microfluidics, bioprinting covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held the largest share in 2015 due to high prevalence of chronic diseases in this region. Chronic diseases account for majority of the healthcare expenditure incurred in this country. As a result, the huge chronic disease burden drives the demand for 3D cell culture techniques owing to its wide applicability. Moreover, availability of government funds and investments by private organizations is further expected to drive this vertical.
The “2020: A New Vision” initiative by the U.S. Department of Health and Human Services recognizes regenerative medicine at the forefront of healthcare. The transformative impact of using regenerative medicine clinically is of utmost importance in technological innovation and progress in translation. Successful treatment of lymphoma, myeloma, or leukemia, and remarkable advances in transplantation have propelled adoption of regenerative approaches in clinical practices.
Hematopoietic stem cell transplants have been proven to be effective treatment options for metabolic storage diseases, immunodeficiency, and extracellular matrix disorders along with hematological malignancies. Thus, rapid technological advances in the country are expected to influence market growth. Moreover, companies such as Nano3D Biosciences and Thermo Fisher Scientific, Inc., which are engaged in providing 3D cell culture products are expected to witness significant growth owing to increasing adoption of 3D cellular models.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. 3d cell culture market , including forecasts for subscribers. This country databook contains high-level insights into U.S. 3d cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account